Correlation of p53 protein expression with gene mutation in gall-bladder carcinomas

被引:36
作者
Itoi, T
Watanabe, H
Yoshida, M
Ajioka, Y
Nishikura, K
Saito, T
机构
[1] NIIGATA UNIV,SCH MED,DEPT PATHOL 1,NIIGATA,JAPAN
[2] TOHO UNIV,SCH MED,DEPT INTERNAL MED 3,KANAGAWA,JAPAN
关键词
cytologic atypia; gall-bladder carcinoma; p53; alteration;
D O I
10.1111/j.1440-1827.1997.tb04535.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The correlation of p53 protein expression and p53 mutation of 33 gall-bladder carcinomas was studied according to the depth of invasion and grade of cytological atypia. Overexpression of p53 protein was detected by immunostaining in seven (70.0%) of 10 intramucosal and in 16 (69.6%) of 23 invasive carcinomas. p53 mutation was detected in five (71.4%) of the seven intramucosal carcinomas with overexpression and in eight (50.0%) of the 16 invasive cancers with overexpression and in one (10%) of the 10 non-overexpressing carcinomas at exons 5-8 by nested polymerase chain reaction-single-strand conformation polymorphism. The overexpression of p53 protein was present in nine (56.3%) of 16 low-grade carcinomas and in 14 (82.3%) of 17 high-grade carcinomas. in cases of overexpression, p53 mutation was detectable in four (44.4%) of nine low-grade and in nine (64.3%) of 14 high-grade carcinomas. In total, p53 mutation was verified in 56.5% (13/23) of cases involving protein overexpression and in 10% (1/10) of cases of non-overexpression. The sensitivity of p53 mutation was 56.5% (13/23), the specificity was 90.0% (9/10) and the validity was 1.47. In conclusion, our study indicates that p53 protein overexpression correlates well with gene mutation and that p53 alteration may be related to increasing grade of cytologic atypia of carcinomas.
引用
收藏
页码:525 / 530
页数:6
相关论文
共 20 条
[1]  
BASS IO, 1994, J PATHOL, V172, P5
[2]   P53 PROTEIN ACCUMULATION IN EUROPEAN HEPATOCELLULAR-CARCINOMA IS NOT ALWAYS DEPENDENT ON P53 GENE MUTATION [J].
BOURDON, JC ;
DERRICO, A ;
PATERLINI, P ;
GRIGIONI, W ;
MAY, E ;
DEBUIRE, B .
GASTROENTEROLOGY, 1995, 108 (04) :1176-1182
[3]  
CESARMAN E, 1993, AM J PATHOL, V143, P845
[4]  
ESRIG D, 1993, AM J PATHOL, V143, P1389
[5]  
HENSEL CH, 1991, ONCOGENE, V6, P1067
[6]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53
[7]   INCREASED EXPRESSION OF MUTANT FORMS OF P53 ONCOGENE IN PRIMARY LUNG-CANCER [J].
IGGO, R ;
GATTER, K ;
BARTEK, J ;
LANE, D ;
HARRIS, AL .
LANCET, 1990, 335 (8691) :675-679
[8]   P53 AND C-ERBB-2 PROTEIN EXPRESSION IN ADENOCARCINOMAS AND EPITHELIAL DYSPLASIAS OF THE GALL-BLADDER [J].
KAMEL, D ;
PAAKKO, P ;
NUORVA, K ;
VAHAKANGAS, K ;
SOINI, Y .
JOURNAL OF PATHOLOGY, 1993, 170 (01) :67-72
[9]  
KIKUCHIYANOSHITA R, 1992, CANCER RES, V52, P3965
[10]   THE P53 TUMOR SUPPRESSOR GENE [J].
LEVINE, AJ ;
MOMAND, J ;
FINLAY, CA .
NATURE, 1991, 351 (6326) :453-456